In the US, MultiHance (gadobenate dimeglumine systemic) is a member of the drug class magnetic resonance imaging contrast media and is used to treat CNS Magnetic Resonance Imaging and Magnetic Resonance Angiography.
- MULTIHANCE 0.5M SOLUTION FOR INJECTION (Leaflet)
- MULTIHANCE 529 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE (Leaflet)
Ingredient matches for MultiHance
Gadobenic Acid is reported as an ingredient of MultiHance in the following countries:
- New Zealand
Gadobenic Acid dimeglumine (a derivative of Gadobenic Acid) is reported as an ingredient of MultiHance in the following countries:
- Bosnia & Herzegowina
- Croatia (Hrvatska)
- United Kingdom
Gadopentetic Acid dimeglumine (a derivative of Gadopentetic Acid) is reported as an ingredient of MultiHance in the following countries:
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.